gp0532

The go-to-market motion in one picture

Most agencies describe their growth engine as "referrals plus some marketing," which is not a motion — it is two disconnected activities that happen to share a P&L. The 2027 playbook treats demand as a single system with three intake doors that all land in the same intake queue, the same CRM, and the same outcome ledger: the institutional door (hospitals, skilled nursing facilities, physician groups, ACOs), the consumer door (search, local presence, community reputation), and the payer door (Medicare Advantage plans, risk-bearing provider groups, and health-system-owned plans contracting for post-acute performance).

The reason to draw it as one picture is that the doors compete for the same finite capacity. A home health agency's binding constraint is almost never leads — it is clinician availability. Every admission you accept consumes a nurse or therapist visit slot that cannot be sold twice. So the motion has to include a capacity check, not just a conversion funnel. Agencies that bolt a lead-generation program onto a staffing-constrained operation generate the worst possible outcome: they raise expectations with referrers and families, then miss the start-of-care window, and the referral source quietly reroutes volume to a competitor who answers on the first call.

Trace one patient through the motion end to end. A discharge planner at a regional hospital decides on Tuesday morning that a 78-year-old post-CHF-exacerbation patient needs skilled home health. That decision is made in a compressed window — often under an hour, sometimes with the discharge already scheduled for that afternoon. The planner opens the referral-management platform embedded in the EHR and sees a list of agencies with acceptance rates, star ratings, and geographic coverage. Whoever accepts fastest, with a confirmed first-visit date, usually gets the case. Your marketing has done its job weeks earlier by making sure you appear on that list with credible numbers next to your name; your operations does its job in the next fifteen minutes by accepting and scheduling.

Now trace the consumer path, which behaves nothing like the institutional one. An adult daughter three states away searches at 11 p.m. after her father's second fall in a month. She does not know the difference between skilled home health (physician-ordered, typically Medicare-covered, intermittent, clinical) and non-medical home care (private pay or long-term-care insurance, hourly, custodial). She calls three agencies. Two send her to voicemail. The third answers, explains the distinction in plain language, tells her honestly that her father may qualify for the Medicare benefit and how to get the order from his physician, and books an assessment. That agency wins — and often wins the private-pay companion hours too, which carry very different margins.

The loop at the bottom is the part most agencies never build. Outcomes are treated as a compliance artifact rather than a growth asset. When you route the outcome ledger back into referrer scorecards and consumer proof points, the motion compounds: good episodes buy you more referrals, better referrals let you choose patients you serve well, and better patient mix improves the outcomes you report next quarter. Break that loop and you are back to buying volume with pastries and paid search.

One adjacent lesson worth borrowing: this is structurally the same problem faced by hospice, private-duty home care, home infusion, and outpatient therapy — all capacity-constrained, referral-heavy, reputation-sensitive services. The playbooks are close enough that agencies operating multiple lines should run one intake function and one CRM across them, with routing rules rather than separate go-to-market teams. The cross-sell alone justifies it: a family that starts with skilled home health after a hospitalization frequently needs private-duty hours during recovery and, eventually, hospice. Losing that continuity to a competitor because two divisions used different systems is a self-inflicted revenue leak.

Who owns what across the revenue org

Home health agencies are chronically ambiguous about ownership, and the ambiguity shows up as finger-pointing when volume dips. Marketing blames sales for not converting; the liaison team blames intake for slow acceptance; intake blames scheduling for having no clinician; scheduling blames recruiting. The fix is not a reorg — it is a written definition of who owns each stage, what number they are accountable for, and what handoff they owe the next function.

Community liaison / business development. Owns institutional relationships and the account plan for each referral source. Their number is not "visits made" — a vanity metric that rewards windshield time — but referral volume and conversion from a defined set of scored accounts. A liaison covering fifteen high-value accounts with a documented quarterly plan will outperform one covering sixty on a rotation. Their handoff obligation is a clean referral with clinical detail sufficient for intake to make an acceptance decision without three callbacks.

Intake and central authorization. Owns the single most leveraged number in the entire motion: time from referral received to accept/decline decision, and time from acceptance to confirmed start of care. In practice this team also owns insurance verification, authorization, and the physician order chase — the unglamorous work that decides whether an admission ever becomes billable revenue. Understaffing intake to save payroll is one of the most expensive false economies in the industry, because every hour of delay measurably raises the chance the referral source moves the case.

Marketing. Owns the consumer door and the credibility layer for the institutional door. That means local search presence, the website as conversion instrument, reputation management, content that explains coverage rules in plain language, and the production of referrer-facing scorecards. Marketing in this sector is closer to demand capture than demand creation — nobody is talked into needing home health — so the discipline is being present, fast, and trustworthy at the moment of need, not clever.

Clinical leadership. Owns the outcomes that the entire GTM engine sells. This is the uncomfortable truth of value-based post-acute care: your director of nursing has more influence over next year's referral volume than your marketing budget does. Star ratings, readmission performance, and patient-experience scores are simultaneously reimbursement inputs and marketing assets. Clinical leadership must therefore sit in growth reviews, not just quality meetings.

Recruiting and workforce. Owns supply. In a labor market where clinician turnover routinely runs high and open territories quietly cap growth, recruiting is a revenue function. Any agency planning a demand push without a parallel hiring plan is planning to decline referrals — which does more long-term damage than never having pursued the volume. Treat recruiting pipeline as a growth metric and review it in the same meeting as referral pipeline.

Finance / revenue cycle. Owns whether the work converts to cash. Denials, missed authorizations, late documentation, and LUPA-threshold visit patterns turn revenue into write-offs long after marketing has celebrated the admission. Give finance visibility into which referral sources and patient segments generate clean claims versus chronic rework, because that data should redirect where business development spends its time.

The practical mechanism that ties these together is a weekly growth stand-up of forty-five minutes with a fixed agenda: referral volume by source versus plan, acceptance and decline reasons, time-to-start-of-care, open clinician capacity by discipline and territory, consumer inquiry volume and response time, and any outcome measure trending the wrong way. No slides. One dashboard. Decisions taken in the room. Agencies that run this meeting consistently for two quarters typically find their biggest wins were not new channels at all, but the removal of internal friction they had stopped noticing.

Metrics, targets, and realistic ranges

Instrument the motion or you are guessing. The metrics below are the ones that actually move behavior in home health; where I give ranges, treat them as planning starting points to calibrate against your own baseline rather than industry law, since acuity mix, geography, payer composition, and labor market swing every one of them.

Speed-to-response (consumer). Measure from inbound call, form, or chat to a live human conversation. The realistic goal is minutes during business hours and under an hour after hours, because families contact multiple agencies in one sitting and the first substantive conversation anchors the decision. Track after-hours separately — that is where most agencies quietly lose cases, and where an answering service that only takes a message is nearly as bad as no answer at all.

Referral-to-acceptance decision time. Same-day is the working standard; same-hour is the competitive one. Log every decline with a structured reason code (out of area, no capacity in discipline, payer not contracted, patient not appropriate). Those reason codes are a growth roadmap: if a third of declines are "no PT capacity in the north territory," your problem is recruiting, not marketing, and no campaign will fix it.

Time to start of care. Measure referral to first billable visit. Regulatory expectations and payer contracts often set outer bounds; competitive reality sets a tighter one. Report the median and the 90th percentile — the tail is what referrers remember, because one patient who waited five days generates more conversation at the discharge desk than twenty who were seen next day.

Referral conversion rate by source. Referrals received versus patients admitted, cut by source. A source converting far below your average is either sending inappropriate patients (fix with education and better scoping of what you take) or you are declining them (fix with capacity, or stop spending liaison time there). Either way the number is only useful when segmented; the blended average hides everything.

Cost per admission by channel. Fully loaded — liaison compensation and travel allocated to institutional, ad spend plus content and site costs allocated to consumer. Most agencies are startled the first time they compute this, because a liaison's loaded cost divided by incremental admissions from their accounts frequently exceeds what they assumed digital was costing per admission. That is not an argument to fire liaisons; it is an argument to concentrate them on accounts where the marginal return is real.

Recertification and episode continuity. In an episodic payment world, patients who complete an appropriate full course of care produce materially different economics than those who drop off after two visits. Track visit utilization against plan of care, and watch for patterns near payment thresholds — both because underserving patients is a clinical failure and because it invites scrutiny.

Readmission rate and patient-experience scores. These are your reimbursement inputs under value-based purchasing and your most credible marketing claims. Track them by referral source and by condition cohort, not just agency-wide, so you can tell a cardiology service line something specific about their patients rather than a generic average.

Clinician capacity and turnover. Open visit slots by discipline and territory, and rolling turnover. This belongs on the growth dashboard because it is the ceiling on everything above it. An agency with strong demand and 30% annual clinician turnover is running a treadmill where growth spend leaks out through the staffing hole faster than it accumulates.

Reputation surface. Review volume and recency across your local listings, plus response rate. Recency matters more than raw count for both ranking and human trust — a dozen reviews from the last six months outperform sixty from four years ago. Set an operational trigger that asks satisfied families for a review at a natural moment in the episode, and require a human, accountable response to every critical review within a set window.

One caution on targets: do not import benchmarks wholesale from a national report and hand them to a branch as a quota. Home health economics are intensely local. A dense urban territory where a nurse completes six visits a day supports a completely different cost-per-admission and margin profile than a rural territory where drive time caps her at three. Set ranges per territory from your own trailing data, then push each one toward its own best quarter rather than toward someone else's average.

Where the motion breaks down

Failure modes in this sector are remarkably consistent, and nearly all of them are operational problems wearing a marketing costume.

Growth outruns capacity. The most common one. Leadership funds a demand push, referrals rise, intake starts declining cases, and referral sources — who experience declines as unreliability, not as a compliment — reroute. The damage outlasts the campaign, because the discharge planner's habit resets and habits are sticky. The discipline is to sequence hiring ahead of demand generation in any territory you intend to grow, and to hold marketing spend flat in territories that are already declining referrals for capacity.

The liaison relationship substitutes for evidence. A well-liked liaison can hold volume for a while on goodwill alone. But as post-acute network narrowing and preferred-provider arrangements spread, the decision increasingly moves from the individual planner to a system-level committee looking at performance data. An agency whose entire moat is one person's relationships is one job change away from a cliff. Build the scorecard habit while the relationships are still strong, not after you have lost an account.

Compliance risk in marketing language. Healthcare marketing carries regulatory constraints that most general marketers have never encountered — rules governing patient inducements, remuneration for referrals, and claims about Medicare coverage are not areas for creative latitude. A "free gift for signing up" campaign that would be unremarkable in retail can be a serious problem here. Route campaign copy, referral-partner arrangements, and any outcome claim through a defined review step. The lightweight version — a named reviewer, a 48-hour SLA, a checklist — costs almost nothing and prevents the category of mistake that ends careers.

Chasing volume into unprofitable mix. Undifferentiated demand generation grows admissions and shrinks margin simultaneously. Cases outside your clinical strengths, in territories with punishing drive times, or under payer contracts priced below your cost to serve, will do that reliably. Segment your trailing episodes by condition, acuity, geography, and payer, find where you deliver strong outcomes at sustainable margin, and aim the engine there. Saying no to a whole segment is a legitimate growth strategy.

Intake as a bottleneck nobody measures. Referrals arrive by fax, portal, phone, and EHR integration, and land with different people. Nobody owns the clock. Weeks later the agency wonders why conversion is soft. Centralize intake, put every referral into one queue with a timestamp, and publish the response-time number weekly. This single change frequently produces more admissions than any campaign, at essentially zero incremental cost.

Digital experience that fails its actual audience. Sites built for a general audience — small type, low contrast, multi-step forms, a buried phone number, no explanation of the difference between covered skilled care and private-pay custodial hours — bleed conversions from a population skewing older and often navigating a crisis. Accessibility here is a revenue feature, not a compliance checkbox.

Silence after the episode ends. No outcome report to the referrer, no follow-up with the family, no request for a review, no handoff to an adjacent service line the patient now needs. The most expensive lead in home health is the one you already served and then forgot. Building a simple post-episode sequence — outcome summary to the source, satisfaction check with the family, review request, and an appropriate offer for continuing support — recovers a surprising amount of volume from work you already did.

How to sequence the build

Do not attempt all of this at once. The sequence below front-loads the changes that produce compounding returns and cost the least, and defers the ones that only pay off once the foundation exists.

Phase one, roughly the first month: instrument and stop the leaks. Centralize intake into one queue with timestamps. Start logging decline reasons with structured codes. Claim and fully complete every local business listing with accurate service areas and hours. Put a human on the phone during expanded hours and audit your own after-hours experience by calling yourself at 9 p.m. Nothing here requires a budget approval, and the diagnostic value is immediate — most agencies discover at least one silent failure in week one.

Phase two, roughly months two and three: build the evidence layer. Assemble your outcome data into a referrer-facing scorecard: readmission performance, time to start of care, patient-experience scores, star measures, segmented by the cohorts each account actually sends. Score your referral sources on volume, conversion, acuity mix, and outcome performance, then reallocate liaison coverage accordingly. Rebuild the website around clarity and speed rather than aesthetics — plain-language coverage explanations, prominent contact, short forms, real family stories, high contrast, mobile first.

Phase three, roughly months four through six: reduce friction and add integration. Connect to the referral-management platforms your major hospital partners use so referrals arrive and are accepted without phone tag. Stand up the post-episode loop: outcome report to the source, satisfaction check and review request with the family, appropriate handoff to adjacent services. Pair every planned demand increase with a recruiting plan for the specific discipline and territory it will consume.

Phase four, months six and beyond: pursue payer and risk relationships. Only now, with credible data and reliable operations, does it make sense to approach Medicare Advantage plans or risk-bearing groups with a performance-based proposition. Start with a scoped pilot on a defined population, agree on the measures before it begins, and report against them relentlessly. Agencies that skip to this phase first, without the evidence layer, arrive with nothing to negotiate on except price — which is the one dimension where a small agency cannot win.

A note on sequencing under pressure: if leadership demands growth this quarter and phase four sounds too slow, the honest answer is that phases one and two typically produce the fastest incremental admissions anyway. Response time, intake centralization, and listing accuracy convert demand that already exists. Payer contracts are a two-to-four-quarter effort at best. Selling that timeline internally is part of the job.

Related questions

How is this different from a private-duty home care playbook?

Private-duty is largely private-pay and consumer-led, so the consumer door dominates and the payer door barely exists. Referral sources skew toward elder-law attorneys, care managers, and communities rather than discharge planners. Response speed and caregiver supply matter even more; regulated outcome measures matter less.

Should a small agency invest in local search or in liaisons first?

Fix listings, response time, and intake first — those cost little and convert existing demand. Liaisons are the bigger lever for skilled home health volume but only once you can reliably accept and start cases, since a liaison selling unreliable service damages accounts.

What breaks first when an agency grows fast?

Clinician capacity, then intake response time. Referral sources experience both as declines and delays, and reroute volume within weeks. Sequence hiring ahead of demand generation in every territory you intend to grow.

How do quality star measures affect growth, not just payment?

Health systems narrowing post-acute networks screen on published performance. Star ratings and readmission data appear next to your name in referral platforms, so they function as both reimbursement inputs and the first filter a case manager applies.

Can one CRM serve home health, hospice, and private duty?

Yes, and it should. One intake function with routing rules preserves continuity when a patient moves between service lines. Separate systems lose that transition to competitors, which is pure avoidable revenue leakage.

FAQ

How long does it take to see results from a rebuilt go-to-market motion? The operational fixes — centralized intake, faster response, corrected local listings, after-hours coverage — often show up in admissions within four to eight weeks because they convert demand that already exists. The evidence layer and account reallocation typically take a quarter to show a trend. Payer partnerships are a two-to-four-quarter effort.

Do I need a large marketing budget to compete with national agencies? No. The highest-return moves in this sector are operational speed, accurate local presence, actively managed reviews, and honest outcome reporting to referrers — none of which scale with budget. National competitors rarely beat a well-run local agency on responsiveness or on the community reputation that drives family choice.

Should sales report to marketing, or stay separate? Keep the liaison team close to clinical leadership and intake rather than under a marketing org, because their credibility rests on operational delivery. What matters more than the reporting line is a shared dashboard and a weekly growth stand-up where liaison, intake, clinical, and recruiting all sit in the same room.

How do I handle a referral source we can no longer serve well? Tell them directly and early, with the reason and a timeline. Referral partners forgive an honest "we are at capacity in that territory through next month" far more readily than repeated silent declines. The relationship survives candor; it rarely survives unreliability.

What is the single most overlooked growth metric? Time from referral received to accept-or-decline decision, with declines coded by reason. It is cheap to measure, it directly predicts conversion, and the decline reason codes tell you exactly whether your constraint is recruiting, geography, payer contracting, or patient fit.

How should marketing claims be reviewed before they publish? Route anything touching coverage, outcomes, comparisons, or incentives through a named reviewer with a short turnaround and a written checklist. Healthcare advertising rules around inducements and referral remuneration are unforgiving, and the cost of a violation dwarfs any conversion lift from an aggressive claim.

Sources

• https://www.cms.gov/medicare/quality/home-health
• https://www.cms.gov/medicare/payment/prospective-payment-systems/home-health
• https://www.medicare.gov/care-compare/
• https://oig.hhs.gov/compliance/physician-education/
• https://www.ftc.gov/business-guidance/advertising-marketing
• https://medpac.gov/document-type/report/
• https://www.ahrq.gov/cahps/surveys-guidance/hhcahps/index.html
• https://www.bls.gov/ooh/healthcare/home-health-and-personal-care-aides.htm
• https://www.nahc.org/

Related on PULSE

• [Inbound demand-capture GTM playbook in 2027](/knowledge/gp0511)
• [Sales-assisted PLG for mid-market in 2027](/knowledge/gp0510)
• [Reseller and VAR channel GTM playbook in 2027](/knowledge/gp0509)
• [International and geo-expansion GTM playbook in 2027](/knowledge/gp0508)
• [Vertical SaaS go-to-market playbook for healthcare in 2027](/knowledge/gp0507)